The human papillomavirus 16 E5 protein, the least well-studied of the three known oncogenic HPV proteins, was reported in 2012 to be a viroporin [REF].
Because some viroporins are essential for viral propagation, they are often considered to be appealing drug targets for development of antiviral drugs [REF].